Strategies for pharmaceutical resilience: navigating supply chain disruptions, meeting pandemic medication demand, and introducing new pharmaceuticals in disruptive times

Ashwin Yadhav Kumar and Konstantinos Nikolopoulos

Chapter 7 in Forecasting, Planning and Strategy in a Turbulent Era, 2025, pp 214-267 from Edward Elgar Publishing

Abstract: This chapter examines the practices of predicting the effects of supply chain disruptions on pharmaceutical production, foreseeing the demand for necessary drugs during pandemics, and organizing the introduction of novel pharmaceuticals during disruptive events. It emphasizes that, to ensure drug availability, predict demand during crises, and successfully launch new pharmaceuticals, the pharmaceuticals business must forecast and plan for disruption.

Keywords: Supply chains; Supply chain disruption; Pharmaceuticals; COVID-19 (search for similar items in EconPapers)
Date: 2025
ISBN: 9781035317233
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.elgaronline.com/doi/10.4337/9781035317240.00012 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:elg:eechap:22585_8

Ordering information: This item can be ordered from
http://www.e-elgar.com

Access Statistics for this chapter

More chapters in Chapters from Edward Elgar Publishing
Bibliographic data for series maintained by Darrel McCalla ().